Biosimilars Forum Welcomes PBM Transparency Act
US Proposals Would See Spread Pricing Outlawed And Rebates Disclosed
Senators Maria Cantwell and Chuck Grassley have introduced a bill which would limit pharmacy benefit managers’ ability to engage in “unfair and deceptive” business practices, a move which has been welcomed by the Biosimilars Forum.
